To manage the development and progression of glaucoma, researchers at Stanford University have developed a biocompatible suprachoroidal spacer implant.
Stanford researchers develop a surgical technique to access the optical nerve head from tunneling through the suprachoroidal space (SCS) for drug delivery applications.